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BACKGROUND: Tissue micro-arrays (TMAs) are increasingly used to generate data of the molecular phenotype of tumours in clinical
epidemiology studies, such as studies of disease prognosis. However, TMA data are particularly prone to missingness. A variety of
methods to deal with missing data are available. However, the validity of the various approaches is dependent on the structure of the
missing data and there are few empirical studies dealing with missing data from molecular pathology. The purpose of this study was to
investigate the results of four commonly used approaches to handling missing data from a large, multi-centre study of the molecular
pathological determinants of prognosis in breast cancer.
PATIENTS AND METHODS: We pooled data from over 11000 cases of invasive breast cancer from five studies that collected information
on seven prognostic indicators together with survival time data. We compared the results of a multi-variate Cox regression using four
approaches to handling missing data – complete case analysis (CCA), mean substitution (MS) and multiple imputation without
inclusion of the outcome (MI ) and multiple imputation with inclusion of the outcome (MIþ). We also performed an analysis in
which missing data were simulated under different assumptions and the results of the four methods were compared.
RESULTS: Over half the cases had missing data on at least one of the seven variables and 11 percent had missing data on 4 or more.
The multi-variate hazard ratio estimates based on multiple imputation models were very similar to those derived after using MS, with
similar standard errors. Hazard ratio estimates based on the CCA were only slightly different, but the estimates were less precise as
the standard errors were large. However, in data simulated to be missing completely at random (MCAR) or missing at random
(MAR), estimates for MIþ were least biased and most accurate, whereas estimates for CCA were most biased and least accurate.
CONCLUSION: In this study, empirical results from analyses using CCA, MS, MI  and MIþ were similar, although results from
CCA were less precise. The results from simulations suggest that in general MIþ is likely to be the best. Given the ease of
implementing MI in standard statistical software, the results of MIþ and CCA should be compared in any multi-variate analysis where
missing data are a problem.
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Missing observations are frequently encountered in all types of
epidemiological and clinical studies, no matter how carefully
designed or how hard investigators try to prevent the problem
(Van der Heijden et al, 2006). Missing data are usually classified
into three types: missing completely at random (MCAR), missing
at random (MAR) and missing not at random (MNAR). Where the
probability that an observation is missing is not related to any
other subject characteristics, the data are MCAR. This means
that whether or not a data point is missing does not depend on
observed or unobserved data. Where the probability that an
observation is missing depends only on observed information for
that subject, the data are MAR. Where the probability that an
observation is missing depends on information that is not
observed, the data are MNAR (Schafer, 1997; Little and Rubin,
2002; Rubin, 2004).
In clinical epidemiological studies of cancer, tissue micro-arrays
(TMAs) are commonly used to generate data on multiple
molecular markers in hundreds or thousands of tumours. Tumour
characteristics may then be evaluated for association with other
clinical or pathological features – disease progression or prognosis
is often of particular interest. However, data generated from
TMAs are particularly prone to missingness for a variety of
technical reasons. Moreover, missingness of TMA data tends to be
correlated across variables.
There are three major approaches to handling missing data:
deletion-based methods, in which observations with missing data
are excluded from the analysis, simple replacement methods, in
which the missing data are replaced by plausible values based on
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savailable data for that variable, and model-based or conditional
methods, where the missing data are replaced by values estimated
from models that utilise the available data for all the variables in
the dataset. The most commonly used method for dealing with
missing data is complete case analysis (CCA), a deletion-based
method. CCA may be preferred under the situation in which the
sample size is large, the proportion of missing data is small and the
missing data mechanism is approximately MCAR (Kim and Curry,
1977). However, even when data are MCAR, loss of data will
result in loss of precision (larger standard errors), particularly with
multivariate data analysis. Where data are MAR or MNAR, CCA
can be biased (Little, 1992; Greenland and Finkle, 1995; Schafer
and Graham, 2002).
An alternative approach is to use methods that fill-in, or impute,
the missing data. Among the simple replacement methods, mean
substitution (MS), which is also known as overall mean imputa-
tion, is commonly used. It is a simple, unconditional method that
does not depend on observed data for other variables in the
imputation. However, MS may also result in biased estimated
where data are not MCAR, but the estimates are more precise than
with CCA (Donders et al, 2006). A somewhat more sophisticated
approach is to fill in missing values for each subject with values
predicted from the rest of the data (model-based methods or
conditional imputation). When missing data are not MCAR, single
conditional imputation tends to result in less biased parameter
estimates than CCA or MS, but the standard errors will be
underestimated if the data are treated as a dataset with no missing
values (Greenland and Finkle, 1995; Van der Heijden et al, 2006).
Formulae for correcting the standard errors for single conditional
imputation can be complex and multiple imputation (MI) has been
proposed as an alternative. In MI, multiple copies of each dataset
are generated, each with missing values replaced by values
randomly generated under a specified model that utilises the rest
of the data. Each dataset is analysed as if it were complete and the
results from each are then combined in a manner that takes
account of imputation variability to obtain the correct standard
errors. MI is now available in standard statistical software and is
relatively straightforward to implement. MI, like other imputation
methods, produces parameter estimates that are more precise than
CCA and has also been shown in many studies to generate
unbiased results under a variety of scenarios for missing data
(Greenland and Finkle, 1995; Van der Heijden et al, 2006; Ambler
et al, 2007). Nevertheless, MI may not be superior under some
circumstances (van Buuren et al, 1999). It is thus apparent that no
method of dealing with missing data is appropriate under all
conditions, and the best approach will depend on the degree of
data missingness and the structure of the underlying missing data
– correlations of missing covariate and outcome data.
Different approaches have often been compared using simulated
data. However, there are few published studies that have compared
methods using large, empirical datasets. Given that the validity of
different approaches depends on the structure of missing data in a
given dataset, it is important to evaluate different methods using a
variety of empirical data. Ambler et al (2007) compared different
methods using a large dataset investigating outcome after cardiac
surgery. Correlations between covariates in this dataset were weak.
The results suggested that CCA produced unreliable risk estimates,
whereas the results of MI were more accurate. However, they
suggested further research based on data with stronger correla-
tions between variables and speculated that MI would also perform
best under these circumstances.
Dawson et al (2010) recently published an evaluation of the role
of oestrogen receptor (ER), progesterone receptor (PR), human
epidermal growth factor receptor-2 (HER2) and B-cell lymphoma 2
(BCL2) expressions in the prognosis of breast cancer using data
generated from TMAs with tumours from more than 11000 breast
cancer cases from five studies. The main multi-variate analysis of
these data was restricted to the 5443 subjects with complete data –
a CCA. The purpose of the analyses we report in this paper was to
evaluate the structure of the missing data in this dataset and to
compare the results of analyses of this dataset using different
imputation approaches to deal with the missing data.
PATIENTS AND METHODS
Study population
We used data from a study on prognosis of breast cancer for which
methods and results have been described (Dawson et al, 2010). In
brief, a total of 11212 early-stage breast cancer cases were
participants in five different studies; The Study of Epidemiology
and Risk Factors in Cancer Heredity (SEARCH), the Nottingham
Breast Cancer Series (NBCS), University of British Columbia Breast
Cancer Series (UBCBCS), British Columbia Cancer Agency Case
Series (BCCA) and Melbourne Collaborative Cohort Study
(MCCS). All studies were approved by the relevant institutional
review boards or ethics committees. The criteria for inclusion
were the availability of tumour tissue, pathological data (tumour
size, tumour grade, lymph node status) and individual clinical
outcome data (breast cancer-specific death). Early-stage breast
cancer was defined as stage I to stage III as per Greene et al (2002).
Breast cancer-specific mortality was the end point of interest,
and was defined as a death where breast cancer was given as
the underlying cause on the death certificate. Seven variables were
included in the prognostic model: nodal status, tumour size,
histopathological grade, ER status, PR status, HER2 status and
BCL2 status.
Statistical analysis
We used the two approaches suggested by Little and Rubin (2002)
to assess the randomness of the missing data in our dataset. Firstly,
prognosis was compared in cases with and without missing data
for each variable. If the data were MCAR, there would be no
difference between the groups. We also assessed the correlation of
data missingness for each pair of variables, which is expected to be
uncorrelated for data MCAR. No guidelines exist for identifying
the level of correlation needed to indicate that the missing data are
not MCAR. Statistical significance tests of the correlations provide
a conservative estimate of the degree of randomness. Significant
correlations in missingness between some pairs of variables
suggest that the data are MAR or MNAR.
A dataset with MS of missing values was generated by simply
replacing missing values with the mean of the available data for
that variable. Multiply-imputed datasets were generated using the
ice command in Stata (Stata Corporation, College Station, TX,
USA), which imputes missing values by using switching regression,
an iterative multivariable regression technique. Missing data
theorists have claimed that good inferences can be made with
the number of imputed datasets (m) as few as 3–5 (Rubin, 2004).
They have argued that the relative efficiency of estimation is very
high under these circumstances compared with an infinite number
of imputations. However, others have suggested that (m) should
approximate the percentage of subjects with some missing data
(Bodner, 2008). We used m¼50 because about half of the cases in
the dataset of this study have incomplete data. All seven prognostic
variables were included in the data imputation model. Dichot-
omous covariates (ER, PR, HER2, BCL2 and node status) were
imputed using logistic regression and polychotomous covariates
(grade and tumour size) were imputed using polytomous logistic
regression. It was suggested that MI models that ignore the
outcome of interest can bias parameter estimates towards the null
(Moons et al, 2006; White and Royston, 2009) and so we also
imputed the missing data, including the outcome of interest in
the imputation model.
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sCox regression analysis stratified by the study was performed to
determine the effect of each prognostic factor and marker on
breast cancer-specific survival after diagnosis. Hazard ratio
estimates were calculated over the 15-year follow-up period using
the Cox model that included all seven prognostic variables. Tests of
the proportional hazards assumption based on Schoenfeld
residuals were not significant for tumour size (P¼0.08), HER2
status (P¼0.62) or BCL2 status (P¼0.2), but were significant for
nodal status (P¼0.01), grade (Po0.0001), ER status (Po0.0001)
and PR status (Po0.0001). These four variables were therefore
treated as time-dependent variables in an extended Cox model
in subsequent analyses. Cox regression was performed on four
datasets: the dataset with complete data, the dataset in which
missing data were replaced by the mean (MS) and the multiply-
imputed datasets – those imputed with and without including
survival time in the imputation model (MIþ and MI ). The
analysis of the multiply-imputed datasets was carried out using
the micombine command in Stata.
Simulations
To provide additional evidence for the results, we simulated
100 datasets with data MCAR and 100 datasets with data MAR
using the subset of cases with no missing data (n¼5443), and to
simulate sampling variation, as well as variation in missing data,
we generated each dataset by bootstrap sampling with replacement
from the complete dataset, and then simulated the missing data on
the bootstrap datasets. We generated the data MCAR by deleting
data for each variable randomly in proportion to the missingness
of the data in the full dataset. The proportion of cases with
complete data in each simulated dataset was lower than that in the
full dataset – 27 percent (1447 of 5443) compared with 49 percent
(5443 of 11212). This is as expected where there is no correlation
between missing data. We generated data MAR with the same
pattern of missingness as in the original dataset, so that the
correlations between missingness in the original dataset were
preserved. In these datasets, the proportion of complete cases
(2593 of 5443) was the same as in the original data. Each of the
simulated datasets was analysed using the four approaches
described above. Cox regression analysis including time-depen-
dent variables as described above is relatively slow – the
multivariate analysis of 50 multiply-imputed datasets taking about
12h. To reduce computation time for the analysis of 200 simulated
datasets, we restricted the analysis to the first 2 years of follow-up
as the proportional hazards assumption is reasonably robust over
such a short time span. We compared the estimates from
the simulated datasets with the estimates from the analysis of the
complete dataset.
All statistical analyses were run using Stata SE10.
RESULTS
Baseline clinical and pathology data from the study subjects are
summarised in Table 1. All seven variables used in the model had
missing values. Of the 78484 possible data points, 13357 were
missing (6 percent) in 5769 patients (51 percent). Table 2 shows
that the least data were missing for ER status (6 per cent) and
the most data were missing for BCL2 status (30 percent).
Supplementary Table 1 shows the number of subjects according
to the number of missing data points. Almost half the subjects
(5443) had a complete set of data for all seven variables, and
47 subjects (0.4 percent) had data on only one variable.
There was a significant difference in survival of patients with
and without missing data for all four IHC markers (P¼0.005, 0.04,
0.001 and 0.04 for ER, PR, HER2 and BCL2 status, respectively)
(Supplementary Figure 1). Those patients with missing data had a
better prognosis, so exclusion of the patients with missing values
would lead to an underestimate of the true survival of the cohort.
A likely explanation is that tumour cores are more likely to be
missing from a TMA if the tumour is small and difficult to sample.
Survival in patients missing tumour grade was better than those
with available data (Po0.001). For nodal status and size
of the tumour, the reverse was true, that is, survival in patients
missing nodal status (Po0.0001) and size of the tumour
Table 1 Baseline characteristics of breast cancer datasets
Variable Number (percent)
Mean age 55 (N/A)
Mean follow-up 8.4 (N/A)
Number of breast deaths 2677 (24)
5-year survival 8002 (71)
Grade
1 1437 (13)
2 4155 (36)
3 4546 (41)
Missing 1074 (10)
Nodal status
Negative 5478 (49)
Positive 4060 (36)
Missing 1674 (15)
Tumour size (cm)
o2 4545 (41)
2–4.9 4664 (41)
5+ 697 (6)
Missing 1306 (12)
ER status
Negative 3037 (27)
Positive 7458 (67)
Missing 717 (6)
PR status
Negative 3963 (35)
Positive 5030 (45)
Missing 2219 (20)
HER2 status
Negative 7068 (63)
Positive 1104 (10)
Missing 3040 (27)
BCL2 status
Negative 2185 (19)
Positive 5700 (51)
Missing 3327 (30)
Abbreviations: BCL2¼B-cell lymphoma 2; ER¼oestrogen receptor; HER2¼human
epidermal growth factor receptor-2; N/A¼not applicable; PR¼progesterone
receptor.
Table 2 Number of missing values for prognostic covariates
Variable Observed Missing (% )
Grade 10138 1074 (10)
Nodal status 9538 1674 (15)
Tumour size 9906 1306 (12)
ER status 10495 717 (6)
PR status 8993 2219 (20)
HER2 status 8172 3040 (27)
BCL2 status 7885 3327 (30)
Abbreviations: BCL2¼B-cell lymphoma 2; ER¼oestrogen receptor; HER2¼human
epidermal growth factor receptor-2; PR¼progesterone receptor.
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s(P¼0.075) was worse than those with available data (Supple-
mentary Figure 2).
The overall number of subjects with complete data would be
expected to be 27 percent of the total if the missing data were not
correlated. That 49 percent of cases had complete data suggest
that missingness is correlated between variables and thus the data
are either MAR or MNAR. The correlation between data
missingness for all prognostic factors shows clear correlations
between missingness for most pairs (Table 3). In particular, the
strongest correlations were between the immunohistochemical
markers, as might be expected for data generated from TMAs.
Taken together, these findings strongly suggest that the data
are not MCAR.
The model coefficients (natural logarithm of hazard ratio) and
standard errors from the multi-variate Cox regression based on the
four approaches to handling missing data are shown in Table 4.
There was little difference in the coefficient estimates for the four
methods, but the standard errors for the CCA were substantially
larger, as would be expected from the smaller sample size. Note
that the underlying ‘true’ estimates for comparison are not known.
Results of the simulations
In contrast, the results from the analyses of the datasets with
simulated missing data were somewhat different. Here the
estimates from the analysis of the 5443 subjects with complete
data are regarded as the underlying ‘true’ estimates for comparison
with the results from CCA, MS, MI  and MIþ analyses of datasets
with missing data simulated as MCAR and MAR.
Table 3 Correlation of missingness in breast cancer prognostic factors
Grade Nodal status Size group ER status PR status HER2 status
Grade 1.00
Nodal status 0.09 1.00
Size group 0.10 0.73 1.00
ER status 0.01  0.03 (0.01) 1.00
PR status ( 0.01) 0.08 0.07 0.41 1.00
HER2 status (0.01) 0.28 0.23 0.36 0.57 1.00
BCL2 status  0.04 0.07 0.05 0.30 0.58 0.57
Abbreviations: BCL2¼B-cell lymphoma 2; ER¼oestrogen receptor; HER2¼human epidermal growth factor receptor-2; PR¼progesterone receptor. Coefficients within
parentheses are not statistically significant (P40.05).
Table 4 Comparison of coefficients (log hazard ratio) and standard errors (s.e.) from analyses based on four methods for handling missing data
Complete case analysis Mean substitution MI  MI+
Variable Coefficient s.e. Coefficient s.e. Coefficient s.e. Coefficient s.e.
Grade 1.05 0.14 1.05 0.10 0.95 0.10 0.97 0.10
Nodal status 1.17 0.13 0.97 0.09 0.97 0.10 1.10 0.10
Tumour size 0.41 0.05 0.45 0.03 0.40 0.04 0.43 0.04
ER status  0.89 0.15  0.93 0.11  0.83 0.11  0.80 0.11
PR status  1.13 0.16  1.00 0.12  0.94 0.12  1.00 0.13
HER2 status 0.27 0.07 0.27 0.05 0.23 0.05 0.26 0.05
BCL2 status  0.26 0.07  0.20 0.06  0.17 0.06  0.20 0.06
Time effect
Nodal status  0.22 0.08  0.13 0.06  0.19 0.06  0.19 0.06
Grade  0.40 0.08  0.37 0.06  0.34 0.06  0.33 0.06
ER status 0.71 0.10 0.68 0.07 0.63 0.08 0.63 0.08
PR status 0.55 0.10 0.49 0.08 0.46 0.08 0.47 0.08
Abbreviations: BCL2¼B-cell lymphoma 2; ER¼oestrogen receptor; HER2¼human epidermal growth factor receptor-2; MI ¼multiple imputation without the outcome;
MI+¼multiple imputation with the outcome; PR¼progesterone receptor.
Table 5 MD and MAD for each imputation method, averaged over 100
simulations
MCAR MAR
CCA MS MI  MI+ CCA MS MI  MI+
MD
Grade  0.06  0.06  0.01  0.03  0.04  0.08  0.02  0.03
Nodal status 0.02 0.03 0.18 0.02  0.02 0.07 0.20 0.02
Tumour size  0.01  0.02 0.04 0.00 0.00 0.02 0.06 0.01
ER status 0.02 0.14 0.05 0.01 0.01 0.17 0.06 0.02
PR status  0.09  0.20  0.27  0.08 0.03  0.22  0.30  0.05
HER2 status  0.01  0.04  0.03 0.04  0.01  0.01  0.05  0.01
BCL2 status 0.02 0.04  0.02 0.03 0.00  0.09  0.06  0.01
MAD
Grade 0.27 0.13 0.12 0.14 0.22 0.11 0.11 0.14
Nodal status 0.20 0.12 0.18 0.11 0.20 0.20 0.20 0.12
Tumour size 0.16 0.09 0.08 0.09 0.15 0.08 0.11 0.11
ER status 0.25 0.17 0.12 0.14 0.23 0.20 0.14 0.15
PR status 0.28 0.24 0.28 0.18 0.29 0.26 0.30 0.18
HER2 status 0.28 0.14 0.10 0.14 0.22 0.15 0.12 0.16
BCL2 status 0.24 0.14 0.11 0.15 0.23 0.19 0.14 0.18
Abbreviations: BCL2¼B-cell lymphoma 2; CCA¼complete case analysis;
ER¼oestrogen receptor; HER2¼human epidermal growth factor receptor-2;
MAD¼mean absolute difference; MAR¼missing at random; MCAR¼missing
completely at random; MD¼mean deviation; MI ¼multiple imputation without the
outcome; MI+¼multiple imputation with the outcome; MS¼mean substitution;
PR¼progesterone receptor. Numbers in bold indicate method with best result
for that variable. Underlined numbers indicate method with worst result for that
variable.
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Figure 1 Confidence limits for multivariate log hazard ratio estimates for each prognostic variable using four approaches of handling missing data in 100
datasets with data-simulated MAR. CCA¼complete case analysis; MS¼mean substitution; MI¼multiple imputation without the outcome and
MIþ¼multiple imputation with the outcome. The horizontal lines represent the true estimates.
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sSupplementary Figure 3 shows the model coefficients for the 200
datasets with missing data simulated as MCAR and MAR under the
four analytic approaches. The difference between these values and
the true value provides an indication of the accuracy and bias of
the analytic approach (Engels and Diehr, 2003). The mean of the
absolute difference provides a measure of accuracy – how close the
estimated values are to the true value. The mean of the difference
provides a measure of whether the estimates tend to be system-
atically over- or underestimated, or biased. These results (Table 5)
show that the values for CCA were more likely to be extreme than
for the other three methods, but the distribution of these values
tended to be unbiased. The values for the other three methods
tended to be less extreme, but for some variables there was
evidence for bias. In particular, for the data-simulated MAR, the
estimates from MS for grade tended to be overestimated, whereas
those for ER status and PR status tended to be underestimated.
Similarly for MI , the HR for nodal status tended to be
underestimated, whereas HR for PR status tended to be over-
estimated. The most consistent results were obtained using MIþ
with little evidence for bias. Figure 1 shows the 95 percent
confidence intervals (CIs) for each log HR estimate for the 100 data
MAR simulations. The CIs for the results of the data simulated as
MCAR are shown in Supplementary Figure 4. This shows that the
CIs for CCA tend to be wider than for the other three methods. For
the data MCAR, the CIs for the CCA, MS, MI  and MIþ excluded
the true value 31, 64, 47 and 26 times, respectively, out of 700
estimates (7 variables and 100 simulated datasets). For the data
MAR, the CIs excluded the true value 73, 96, 67 and 48 times,
respectively, for CCA, MS, MI  and MIþ.
DISCUSSION
The occurrence of missing data is a pervasive problem in the
analysis of epidemiological data. Several possible techniques can
be used to deal with the problem, but the appropriateness of the
methods may depend on the nature of the missing data. We have
evaluated four commonly used methods in the analysis of
molecular pathology data generated using TMAs in the study of
cancer. Such data are particularly prone to correlated missingness.
As expected, the missing data for the seven variables of interest
in our dataset were correlated with each other and with the
outcome of interest, suggesting that the data are MAR or MNAR.
Note that it is not possible to determine which of these possibilities
is correct using the observed data. Under these circumstances, we
might expect MIþ with the model used to impute missing data,
including the outcome of interest to provide the least biased
parameter estimates, with a potential for bias for estimates based
on CCA, MS and MI . However, we found little difference in the
model coefficient estimates for the analyses of the full dataset of
11212 subjects using CCA and both methods of missing data
imputation. This suggests that all four methods generate estimates
that are reasonably robust with large sample sizes, even where a
substantial proportion of the data are missing. The coefficient
standard errors were greater for CCA than for either of the
imputation methods, as would be expected from the considerable
loss of sample size that occurs for CCA.
In contrast, the results of the analysis of the datasets with
missing data simulated as MCAR and MAR varied according to the
approach used. There was no systematic trend for the results of
CCA to either over- or underestimate the true value, that is, there
was no bias, but the CIs were wider than with other approaches. All
seven variables used are established as prognostic factors, and
despite the loss of precision, all the associations were significant at
the 5 percent level. However, with a smaller sample size and/or
smaller effects, some associations might not be detected by CCA
because of the loss of statistical power. Furthermore, as the
number of variables increases, even a small proportion of missing
data for each variable can lead to severely depleted data for CCA
and substantial loss of power. MS and MI  gave similar results.
Confidence limits were small and the point estimates tended to be
closer to the true estimate than with CCA. On the other hand, MS
and MI  systematically under- or overestimated the effects for
some variables.
As shown by others (Rubin and Schenker, 1991; Vach, 1991;
Greenland and Finkle, 1995; Rubin, 1996, 2004; Schafer, 1999; Little
and Rubin, 2002), our results show that MI without the outcome
variable in the imputation model results in bias towards the null
for the regression coefficients. This reflects the fact that missing-
ness of a predictor is commonly related to both other predictors
(covariates) and, directly or indirectly, to the outcome. Conse-
quently, the estimated conditional distribution of the covariate
from which random values are drawn (multiple times) to replace
the missing covariate values will be biased unless the outcome is
included in the imputation mode (Moons et al, 2006).
It has been suggested that where more than 25 percent of cases
have missing data, the loss of precision from CCA is sufficient to
warrant an alternative approach to analysis (Marshall et al, 2010).
However, it is not possible to rank definitively one method over
the other as the choice depends on the relative importance given to
accuracy and bias. There are many factors that may affect the
performance of the different approaches. These include the sample
size, number of variables of interest, the proportion of missing
data for each variable, the correlation between variables, the
correlation between data missingness for the variables and the
underlying association between each variable and the outcome of
interest. As pointed out by Horton et al (2010), all missing data
methods rely on inherently untestable assumptions, and we cannot
draw general conclusions on the most appropriate method of
handling missing data in multivariable prediction research under
all circumstances. Guidelines for reporting analyses potentially
affected by missing data have recently been published and our
results support their main conclusions (Sterne et al, 2009). In
particular, a comparison of the results of different approaches to
handling missing data should be considered.
In conclusion, the results from our empirical analyses using CCA,
MS, MI  and MIþ were similar, although results from CCA were
less precise. The results from simulations suggest that, in general,
MIþ gave consistently more accurate estimates with the least bias.
Given the ease of implementing MI in standard statistical software,
the results of MIþ and CCA should be compared in any multi-
variate analysis where missing data are a problem.
ACKNOWLEDGEMENTS
We thank all the patients who have taken part in these studies
without whom the research would not have been possible. We
thank the SEARCH team, the MCCS investigators and the
Histopathology Core Facility at the CRUK Cambridge Research
Institute for the immunohistochemistry performed on the
SEARCH and BCCA series. We also thank Ian White and Angela
Woods for statistical advice and for their comments on an earlier
draft of the manuscript. AA was supported by PhD scholarship
grant from the Citadel Capital Foundation, Egypt. SJD was
supported by PhD fellowship grant from the Commonwealth
Scholarship and Fellowship Program and Cancer Research UK.
SEARCH is funded by a programme grant from Cancer Research
UK (C490/A10124) and the NIHR Cambridge Biomedical Research
Centre. The immunohistochemical analysis of breast cancers from
the MCCS was supported by Australian NHMRC Grants 209057,
251553 and 504711 and by infrastructure provided by The Cancer
Council Victoria.
Supplementary Information accompanies the paper on British
Journal of Cancer website (http://www.nature.com/bjc)
Immunohistochemical markers in survival analysis of breast cancer
AMG Ali et al
698
British Journal of Cancer (2011) 104(4), 693–699 & 2011 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sREFERENCES
Ambler G, Omar RZ, Royston P (2007) A comparison of imputation
techniques for handling missing predictor values in a risk model with a
binary outcome. Stat Methods Med Res 16: 277–298
Bodner TE (2008) What improves with increased missing data imputations?
Struct Equation Model: Multidiscip J 15: 651–675
Dawson SJ, Makretsov N, Blows FM, Driver KE, Provenzano E, Le QJ,
Baglietto L, Severi G, Giles GG, McLean CA, Callagy G, Green AR, Ellis I,
Gelmon K, Turashvili G, Leung S, Aparicio S, Huntsman D, Caldas C,
Pharoah P (2010) BCL2 in breast cancer: a favourable prognostic marker
across molecular subtypes and independent of adjuvant therapy
received. Br J Cancer 103: 668–675
Donders AR, van der Heijden G, Stijnen T, Moons KG (2006) Review: a
gentle introduction to imputation of missing values. J Clin Epidemiol 59:
1087–1091
Engels JM, Diehr P (2003) Imputation of missing longitudinal data: a
comparison of methods. J Clin Epidemiol 56: 968–976
Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M
(eds) (2002) AJCC Cancer Staging Manual, 6th edn. Springer:
New York, NY.
Greenland S, Finkle WD (1995) A critical look at methods for handling
missing covariates in epidemiologic regression analyses. Am J Epidemiol
142: 1255–1264
Horton NJ, White IR, Carpenter J (2010) The performance of multiple
imputation for missing covariates relative to complete case analysis.
Stat Med 29: 1357
Kim JO, Curry J (1977) The treatment of missing data in multivariate
analysis. Sociol Methods Res 6: 215–241
Little RA (1992) Regression with missing X’s; a review. J Am Stat Assoc 87:
1227–1237
Little RA, Rubin DB (2002) Statistical Analysis with Missing Data.
John Wiley and Sons: New York
Marshall A, Altman DG, Royston P, Holder RL (2010) Comparison of
techniques for handling missing covariate data within prognostic
modelling studies: a simulation study. BMC Med Res Methodol
10: 7
Moons KG, Donders RA, Stijnen T, Harrell Jr FE (2006) Using the
outcome for imputation of missing predictor values was preferred.
J Clin Epidemiol 59: 1092–1101
Rubin DB (1996) Multiple imputation after 18+ years. J Am Stat Assoc 91:
473–489
Rubin DB (2004) Multiple Imputation for Non Rresponse in Surveys. John
Wiley and Sons: New York
Rubin DB, Schenker N (1991) Multiple imputation in health-care databases:
an overview and some applications. Stat Med 10: 585–598
Schafer JL (1997) Analysis of Incomplete Multivariate Data. Chapman &
Hall: London
Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8:
3–15
Schafer JL, Graham JW (2002) Missing data: our view of the state of the art.
Psychol Methods 7: 147–177
S t e r n eJ A ,W h i t eI R ,C a r l i nJ B ,S p r a t tM ,R o y s t o nP ,K e n w a r dM G ,
Wood AM, Carpenter JR (2009) Multiple imputation for missing
data in epidemiological and clinical research: potential and pitfalls. BMJ
338: b2393
Vach W (1991) Biased estimates of the odds ratio in case–control studies
due to the use of ad hoc methods of correcting for missing values for
confounding variables. Am J Epidemiol 134: 895–907
van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of
missing blood pressure covariates in survival analysis. Stat Med 18:
681–694
Van der Heijden G, Donders AR, Stijnen T, Moons KG (2006) Imputation of
missing values is superior to complete case analysis and the missing-
indicator method in multivariable diagnostic research: a clinical
example. J Clin Epidemiol 59: 1102–1109
White IR, Royston P (2009) Imputing missing covariate values for the Cox
model. Stat Med 28: 1982–1998
Immunohistochemical markers in survival analysis of breast cancer
AMG Ali et al
699
British Journal of Cancer (2011) 104(4), 693–699 & 2011 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
s